Seven findings from the early detection research record

Computed from 389 clinical trials, 2,613 papers and 285 NIH grants as the records stand on 2 Nov 2026. Hover a figure for its values, click a trial or paper to open the record, or ask a follow-up question.

Trial starts peaked in 2026, with 45 of the 389 early detection trials in the record.

Phase 1Phase 2Phase 3Phase not stated

98 of 220 Early detection trials are blood & fluid tests.

132 of 389 trials are recruiting patients now; 49 have posted results.

RecruitingNot yet recruitingActive, not recruiting

The 40 most recent starts are shown; 349 earlier trials are left off.

Three trials account for 51% of the 6,232 places where patients can enroll; 253 of 389 run at one site or have none listed yet.

RecruitingActive, not recruitingCompleted

2,412 of the 3,761 research places in the record are in the United States; The University of Texas MD Anderson Cancer Center hosts the most trials, 21.

2,415 places on this map

The University of Texas MD Anderson Cancer Center78
Johns Hopkins University68
Mayo Clinic67
University of Michigan33
Cedars-Sinai Medical Center27
Washington University in St. Louis26
Memorial Sloan Kettering Cancer Center24
Massachusetts General Hospital24
Dana-Farber Cancer Institute24

Outside this map: 260 in China, 165 in Japan, 123 in United Kingdom, 86 in France, 69 in Spain, 64 in Italy, 61 in Germany, 43 in Australia, 40 in IN, 39 in Netherlands, 38 in South Korea, 30 in United States, 25 in CZ, 23 in TW, 19 in BE, 17 in IL, 16 in IR, 15 in PL, 12 in TR, 11 in Denmark, 10 in RO, 10 in CH, 9 in EG, 9 in BR, 9 in SE, 8 in HU, 8 in BG, 7 in PT, 7 in GR, 7 in PR, 6 in SA, 6 in SG, 6 in SK, 5 in ZA, 5 in MX, 5 in IE, 5 in AT, 4 in NO, 4 in MY, 4 in PK, 4 in CL, 4 in UA, 3 in AR, 3 in HK, 3 in BD, 3 in RU, 3 in CY, 2 in FI, 2 in NG, 2 in ID, 2 in RWANDA, 1 in JO, 1 in TH, 1 in LT, 1 in HR, 1 in VN, 1 in MO, 1 in KN, 1 in KW, 1 in PS, 1 in NI, 1 in MA, 1 in QA, 1 in ME, 1 in MU, 1 in IQ, 1 in PH, 1 in NIGERIA, 1 in LU, 1 in IS, 1 in TURKEY (TÜRKIYE), 1 in LV, 1 in GUAM.

Early detection saw papers or trials in 16 years and NIH money in 16; they coincide in 16.

Papers or trials, no NIH dollarsNIH dollars, no papers or trialsBoth

Each square is one topic in one year. Blue years produced work with no new NIH money behind it; amber years were funded but produced no paper or trial that year.

Grants pay out over several years and results lag funding, so a gap here is a question to ask, not a verdict. Switch the view to see dollars or output alone.

Source: NIH RePORTER (National Institutes of Health, NIAAA, NIA, NIAID, NIAMS, NCCIH, NCI (intramural), NIH BX, NCI, NIH Clinical Center, NIH CP, NIH CX, NIDCR, NIDDK, NIBIB, NIEHS, NEI, NIH FD, NIGMS, NICHD, NHGRI, NHLBI, NIH HX, NLM, NIMHD, NIMH, NINDS, NIH OD, NIH RD, NCRR, NCI (intramural), NCATS, FIC, Congressionally Directed Medical Research Programs - Pancreatic Cancer Research Program, Lustgarten Foundation, Pancreatic Cancer Action Network) against Europe PMC papers and ClinicalTrials.gov starts.

Ask about this →